drugset / Trial / NCT02670161

Quality Improvement and Practice Based Research in Neurology Using the EMR

NCT02670161 ↗

Phase 4 Enrolling by invitation 3300 enrolled Endeavor Health
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The investigators will conduct at NorthShore University HealthSystem pragmatic trials using the EMR for 10 common neurological disorders. They will demonstrate the feasibility of subgroup based adaptive assignment of treatments, electronic consenting, and outcomes data capture at the point of care using the EMR. They will identify the most effective treatments for common neurological disorders and seek replication by the NPBRN.

Timeline

Start
2016-05
Primary completion
2026-12
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator ACTH Unknown — —
Comparator Amitriptyline Small molecule — —
Comparator Aspirin Small molecule — —
Comparator Clopidogrel Small molecule — —
Comparator Donepezil Small molecule — —
Comparator Duloxetine Small molecule — —
Comparator Lamotrigine Small molecule — —
Comparator Levetiracetam Other / unclassified — —
Comparator Memantine Unknown — —
Comparator Methylprednisolone Other / unclassified — —
Comparator Omega-3 fatty acids Unknown — —
Comparator Pramipexole Unknown — —
Comparator Pregabalin Small molecule — —
Comparator Propranolol Small molecule — —
Comparator Rivastigmine Small molecule — —
Comparator Rotigotine Unknown — —
Comparator Sumatriptan Unknown — —
Comparator Topiramate Small molecule — —
Comparator Valproic Acid Small molecule — —
Comparator Zolmitriptan Small molecule — —
Comparator rizatriptan Unknown — —
Comparator ropinerole Unknown — —